Table 1. Mutational status by disease... | American Society of Hematology

Table 1.

Mutational status by disease

Disease	JAK2V617F	Total	% JAK2V617F
De novo AML*	1	219	0.5
MDS	2	48	4.2
CMML/aCML	9	116	7.8
B-cell ALL	0	83	0
T-cell ALL	0	93	0
CLL	0	45	0

Disease	JAK2V617F	Total	% JAK2V617F
De novo AML*	1	219	0.5
MDS	2	48	4.2
CMML/aCML	9	116	7.8
B-cell ALL	0	83	0
T-cell ALL	0	93	0
CLL	0	45	0

Three additional patients with AML and JAK2V617F mutations had a preceding MPD.